Comparative rates of androgen production and metabolism in Caucasian and Chinese subjects.
暂无分享,去创建一个
R. Santen | L. Demers | C. Shackleton | G. -. Zhang | G. H. Zhang | S. Santner | C. Wang | B. Albertson | M. Santulli | Cedric H. L. Shackleton | Christina Wang | R. J. Santen | L. M. Demers | Bradley Albertson | Gui-yuan Zhang | Guangkuo Zhang | Michael Santulli
[1] K. Carlström,et al. Testicular and adrenocortical function in men with prostatic cancer and in healthy age-matched controls. , 1997, British journal of urology.
[2] P. Febbo,et al. A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[3] S. Gustafsson,et al. Dihydrotestosterone and testosterone levels in men screened for prostate cancer: a study of a randomized population. , 1996, British journal of urology.
[4] A. Whittemore,et al. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[5] E. Metter,et al. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer , 1995, The Prostate.
[6] J. Masarei,et al. Within- and between-subject variation in, and associations between, serum concentrations and urinary excretion of testosterone and estradiol in Chinese men. , 1995, Clinica chimica acta; international journal of clinical chemistry.
[7] Xiangtien Kong,et al. Preliminary study of the frequency of benign prostatic hyperplasia and prostatic cancer in China. , 1994, Urology.
[8] C. Shackleton. Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research , 1993, The Journal of Steroid Biochemistry and Molecular Biology.
[9] M. Pike,et al. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males , 1992, The Lancet.
[10] R. Hayes,et al. Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study. , 1991, Cancer research.
[11] R. Santen,et al. Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects. , 1991, The Journal of clinical endocrinology and metabolism.
[12] H. Vader,et al. Androstanediolglucuronide: a parameter for peripheral androgen activity before and during therapy with cyproterone acetate. , 1991, Acta endocrinologica.
[13] E. Wynder,et al. Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States. , 1991, International journal of epidemiology.
[14] M. Garg,et al. Alteration of the lipid composition of rat testicular plasma membranes by dietary (n-3) fatty acids changes the responsiveness of Leydig cells and testosterone synthesis. , 1990, The Journal of nutrition.
[15] R. Rittmaster,et al. ANDROSTERONE GLUCURONIDE IS A MARKER OF ADRENAL HYPERANDROGENISM IN HIRSUTE WOMEN , 1990, Clinical endocrinology.
[16] A. Vermeulen,et al. Precursors of plasma androstanediol- and androgen-glucuronides in women. , 1989, Journal of steroid biochemistry.
[17] R. Severson,et al. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. , 1989, Cancer research.
[18] R. Santen,et al. Correlation of Serum 3α-Androstanediol Glucuronide with Acne and Chest Hair Density in Men , 1988 .
[19] V. Toscano,et al. Circulating dihydrotestosterone may not reflect peripheral formation. , 1987, The Journal of clinical investigation.
[20] R. E. Peterson,et al. The prevalence of 5 alpha-reductase deficiency in children with ambiguous genitalia in the Dominican Republic. , 1986, The Journal of urology.
[21] E. Nieschlag,et al. Pharmacokinetics of 19-nortestosterone esters in normal men. , 1985, Journal of steroid biochemistry.
[22] R. E. Peterson,et al. Hormonal evaluation of a large kindred with complete androgen insensitivity: evidence for secondary 5 alpha-reductase deficiency. , 1982, The Journal of clinical endocrinology and metabolism.
[23] I. Mowszowicz,et al. Androgen production and skin metabolism in hirsutism. , 1977, Journal of Endocrinology.
[24] R. Tremblay,et al. Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. , 1974, Contraception.
[25] C. Bardin,et al. The metabolic clearance rate and origin of plasma dihydrotestosterone in man and its conversion to the 5-alpha-androstanediols. , 1971, The Journal of clinical investigation.
[26] C. Bardin,et al. Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism or polycystic ovaries. , 1967, The Journal of clinical investigation.
[27] J. Lobotsky,et al. Plasma testosterone and urinary 17-ketosteroids in Japanese and occidentals. , 1966, The Journal of clinical endocrinology and metabolism.
[28] G. Friedman,et al. 5 alpha-reductase activity and prostate cancer: a case-control study using stored sera. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[29] D. Russell,et al. Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase. , 1992, The Journal of clinical investigation.
[30] C. Muir,et al. The epidemiology of prostatic cancer. Geographical distribution and time-trends. , 1991, Acta oncologica.
[31] D. Mishell,et al. Changes in physiologically free circulating estradiol and testosterone during exposure to levonorgestrel. , 1981, The Journal of clinical endocrinology and metabolism.
[32] W. Haenszel,et al. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. , 1968, Journal of the National Cancer Institute.